Cite
HARVARD Citation
Taoutel, R. et al. (2023). Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant. IJC heart & vasculature. p. . [Online].